# Citius Oncology, Inc. (CTOR): MoatMap facts

As of 28 Oct 2026. Research data, not investment advice.

As of 28 Oct 2026, MoatMap's StockRank for Citius Oncology, Inc. (CTOR) is 11/100, ranked against 24,000+ stocks in 35 markets (Quality 19, Value 32, Momentum 33, each scored against its sector).

- StockRank: 11/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 19, Value 32, Momentum 33: each a 0-100 percentile within Healthcare.
- Position: #23,610 overall, #2,262 in Healthcare.
- Listing: United States, NCM; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 0.611 USD on 27 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/CTOR
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker